Steven E. Hyman

Steven E. Hyman, M.D. is a Harvard University Distinguished Service Professor and Harald McPike Professor of Stem Cell and Regenerative Biology. He serves as Director of the Stanley Center for Psychiatric Research at the Broad Institute of Harvard and MIT, where he is also a Core Institute Member and Principal Faculty at the Harvard Stem Cell Institute. His work bridges neuroscience, psychiatry, and stem cell biology to address serious mental illness through translational research.

Dr. Hyman received his B.A., summa cum laude, from Yale College, an M.A. from the University of Cambridge as a Mellon fellow studying history and philosophy of science, and an M.D., cum laude, from Harvard Medical School.

His research spans multiple domains in neuroscience and psychiatry:

• Neuropsychiatric genetics and large-scale genomic studies of mental disorders
• Stem cell biology applications to psychiatric disorders
• Neurobiology of schizophrenia, bipolar disorder, and autism spectrum disorders
• Development of technology and biomarkers for psychiatric disorders
• Philosophical and ethical dimensions of psychiatric research and practice

Analysis of his recent publications reveals a strong focus on the genetic architecture of psychiatric disorders, particularly schizophrenia, integrating large-scale genomic data with neurobiological mechanisms. His work emphasizes how genetic variants affect synaptic function and brain development, alongside philosophical considerations of psychiatric classification.

Dr. Hyman has received numerous prestigious honors:

• Rhoda and Bernard Sarnat International Prize in Mental Health (2016)
• Fellow of the American Academy of Arts and Sciences
• Fellow of the American Association for the Advancement of Science
• Distinguished life fellow of the American Psychiatric Association
• Member of the National Academy of Medicine

As Director of the Stanley Center, Hyman oversees substantial research funding for psychiatric genetics and neuroscience. The Center has launched major initiatives including the Stanley Global Neuropsychiatric Genetics Initiative and the Schizophrenia Spectrum Biomarkers Consortium. His leadership includes extensive mentorship through these large collaborative projects.

Dr. Hyman directs the Stanley Center for Psychiatric Research, which engages in globally conducted studies of neuropsychiatric genetics, stem cell biology, and neurobiology. The Center includes the Schizophrenia Spectrum Biomarkers Consortium (SSBC), collecting comprehensive biological samples and phenotypic data from individuals with schizophrenia spectrum disorders. The Stanley Global initiative works with research groups worldwide to expand genetic sample collection across diverse populations.